press release

MVision AI receives TGA approval and market authorization for Australia
HELSINKI, Finland – May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under…
Press Release: MVision AI raises 5.4M€ to make same-day cancer treatment the new standard
HELSINKI, Finland – March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered…
MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform
Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education…
YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals
Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime…
AQUILAB Ushers In MVision’s Innovative and Guideline-Compliant AI Segmentation Solution to France
Helsinki – 29th of September 2021 – MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB,…
SERES Medical Brings MVision’s Cutting Edge and Guideline-Based AI Segmentation Solution to the Turkish Market
Helsinki – September 6, 2021 – MVision AI, the software service provider for radiotherapy treatment planning, announces a new distribution partnership with SERES Medical, the…
New Partnership in Switzerland
Helsinki – July 8, 2021 – MVision AI, the cloud-based software service provider for radiotherapy treatment planning, today announces that the company has entered into…
New Partnership in the UK and Ireland
Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing…